SCHEMBL9730754

SCHEMBL9730754

O=S(=O)(O)CC(O)CNC(CO)(CO)CCO

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL167450 0.89 RAB9A (0.36) RAB9A
SCHEMBL7101332 0.89 RAB9A (0.36) RAB9A
SCHEMBL23859620 0.89 RAB9A (0.36) RAB9A
SCHEMBL31033120 0.89 RAB9A (0.36) RAB9A
SCHEMBL30737646 0.87 RAB9A (0.35) RAB9A
SCHEMBL1442777 0.87 RAB9A (0.35) RAB9A
SCHEMBL26137952 0.80
SCHEMBL13359412 0.77
SCHEMBL9570219 0.76
SCHEMBL50906 0.75 PKM (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0507854-A4 METHODS FOR DIAGNOSTING HUMAN INFLUENZA AND 4-POSITION MODIFIED CHROMOGENIC N-ACETYLNEURAMINIC ACID SUBSTRATES FOR USE THEREIN 1992-10-21 EP disclosed
EP-0507854-A1 METHODS FOR DIAGNOSTING HUMAN INFLUENZA AND 4-POSITION MODIFIED CHROMOGENIC N-ACETYLNEURAMINIC ACID SUBSTRATES FOR USE THEREIN. SYMEX CORP (US) 1992-10-14 EP disclosed
WO-1991009972-A1 METHODS FOR DIAGNOSTING HUMAN INFLUENZA AND 4-POSITION MODIFIED CHROMOGENIC N-ACETYLNEURAMINIC ACID SUBSTRATES FOR USE THEREIN SYMEX CORP. (US) 1991-07-11 WO disclosed
WO-1991009975-A1 CHROMOGENIC 7- OR 8-POSITION MODIFIED N-ACETYLNEURAMINIC ACID SUBSTRATES AND METHODS FOR DIAGNOSING HUMAN INFLUENZA THEREWITH SYMEX CORP. (US) 1991-07-11 WO disclosed